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POTENTIAL INTERACTIONS BETWEEN MULTIPLE ETIOLOGIES
AND PATHOGENESIS OF EXPERIMENTAL DISEASES
At least in so far as the understanding of human disease is concerned, the
use of the experimental animal approach is primarily to find a model with
sufficient similarity to the abnormalities observable in the human condition
to give some assurance that insights obtained from these studies will give
valuable clues to the nature of the human process. Certainly from animal
models useful information can be obtained which can guide clinical thought
at a variety of levels. In order of importance for control and management
these are: etiological; pathogenical; diagnostic, including physiological,
biochemical, histological, and cytological potentials; prognostic as to re-
versibility, vicious cycle mechanisms, etc.; and therapeutic.
The worth of an experimental model depends to a great extent on its
similarity to the human counterpart and to a lesser degree on the con-
sistency with which it can be produced. When a model is found that rates
high in these characteristics, it is often possible, by interrupting the experi-
ments, to describe a sequential development of the processes and thus assign
a higher priority to certain steps in the pathogenesis and factors in etiology
over that assigned to others. In this way, it.may also be possible to derive
rather conclusive evidence as to the truly pathogenic findings and the cru-
cial etiologic factors. Once these qualitative studies have been performed,
the next step is usually to find some type of quantitative relationship be-
tween the stressors and the endpoint, or endpoints, which appear to be
most important. Two features of the quantitative relationship of greatest
importance are whether there is a threshold before any effect is seen and
whether there is an all-or-none response or a graded one once a sufficient
dose has been reached.
Certainly for the greatest understanding of the pathogenesis, the earlier
in the process and the more discrete the endpoint the better.
When multiple agents are used in the experimental situation, the prob-
lem becomes more complex. A broad definition of synergy may be used
to describe any situation in which two or more agents appear to give some
type of result over and above that for either agent alone. A much more
exacting definition requires that the result from multiple agents should
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exceed that expected from the summation of the effects of the agents in-
volved. In Table 1, various relationships are given for two agents. With
more than two, the above definition would pertain but the analysis would
be more complex.
In the situation in which multiple agents are involved, the definition of
the endpoint becomes more important than that for single agents. When
a condition results qualitatively from two agents, when neither alone has
given any abnormality, as found by Boren' for carbon particles and NO2,
the total process may be used as the endpoint. To derive further informa-
tion, the quantitative relationship between each agent and each discrete
pathologic process is needed in order to differentiate whether the drugs
are acting together through a common mechanism, or whether each is giv-
ing rise to one part of the process and the composite is recognizable as
similar to the human condition. For example, the association between
chronic bronchitis and emphysema is not well understood but it has been
described that either may occur in the absence of the other. However, these
descriptions have implied that the pure form of either is quite unusual and
the rule is an element of each.' This association is more frequent than would
be expected by a chance coincidence based upon the frequency of each con-
dition. Unless there were a very small percentage of the population who
were susceptible to each and that it was the same segment of the population
for both, the expected frequency of the dual condition would be much less
than either pure form. Thus, if one agent, for example bacteria, caused
chronic bronchitis in animals, and a second agent, such as another bacteria,
TABLE 1. CLASSIFICATION OF INTERACToNS BETWEEN MULTIPLE AGENTS
I. Experiments involving a single endpoint or a sequence of endpoints.
A. Agents which have defined dose-effect curves.
1. Two agents produce less than one or both alone. (Aantagonism; Protection;
Therapeutic)
2. Two agents produce more than either alone but less than that which would
be expected by summation. (Incomplete Addition)
3. Two agents produce that which would be expected by summation. (Simple
Addition or Summation)
4. Two agents produce more than that which would be expected by simple ad-
dition. (Restricted Definition of Synergy)
B. Agents which have an all or none response. One agent has a defined dose-effect
curve.
1. A dose of second agent ineffective by itself increases threshold or decreases
slope of dose-effect curve of second agent. (Antagonism)
2. A dose of second agent ineffective by itself reduces threshold or increases
slope of dose-effect curve of second agent. (Addition or Synergism)
II. Experiments involving more than one endpoint or sequences of endpoints which
may be completely independent.
A. Each agent may be related to only one endpoint.
B. Each agent may be related to each endpoint.
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virus, or even an unusual chemical, caused emphysema, the two together
might give a microscopic and/or clinical picture similar to that often seen
in patients.
However, if each endpoint were analyzed separately with appropriate
dose-effect curves, it would be possible to separate the etiology of the two
processes. On the other hand, if a combination of gases or particles behaved
in such a way that they could initiate an autoimmune mechanism, perhaps
by a haptene action with both bronchial components and alveolar com-
ponents, a single agent (the haptene) may result in both processes; yet
the analysis of each endpoint separately might still allow separation of the
processes were the dose-effect curves for each tissue component different.
As seen in the Table, part I-A, the analyses of the relationship between
agents vary with the nature of the dose-effect curves for each of the agents
in terms of each endpoint. The four possible relationships listed are given
from similar definitions used in describing actions of combinations of
drugs, but rather than using favorable outcome as the endpoint, damage
or death is used in this situation. This type of analysis is important for
situations such as two gases in the atmosphere or a gas in cigarette smoke
and another in air pollution. Epidemiologic studies suggest that there is a
dose-effect curve for these last two factors.
Figure 1 illustrates the importance of precise definitions in describing
combined actions. In panels 1 and 2, it can be seen that agents A and B
may have somewhat similar dose-effect curves but because neither one of
them is linear, it is not possible to add points on them to get estimates of
the results expected by summation. For example, in panel 3, it can be seen
that if the same gas were used under different codes such as A and B and
the levels of activity such as the 20 per cent effective dose (E.D.20) of each
were found and they were added (i.e. dose doubled), an 80 per cent result
would be achieved and synergy in the restricted sense of category IA-4 in
the Table would be surmised, even though it was the same drug being used
twice. However, if a function of the dose and/or a function of the effect
could be found which would allow the description of a linear relationship
on a wide range, addition of the expected effects could legitimately be made.
It is important, however, that for each agent the effect be expressed in
terms of the same function. From the two curves shown in panels 4 and 5,
data are available which allow the construction of a series of lines such as
those in panel 6, best described as ISO-effect curves. Thus the 80 per cent
effective line is the locus of all dose relationships that add together to be
that effective (i.e., 40% effective for A + 40%o for B, 30%o A and 50%o B,
50%o A and 30%o B, etc.). Similarly, the 60 per cent line is a locus of all
dose combinations adding to 60 per cent. The lines then describe the ex-
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pected addition for the effect (endpoint) in question. If a dose of A and
a dose of B were picked that would be expected to give 60 per cent effect
by simple addition and the result obtained were actually 25 per cent as in-
dicated by the "1" in the Figure, there would be antagonism. If result "2"
were obtained, this would indicate more than either alone but less than
complete addition. If 60 per cent effect were found as indicated by "X," it
would be complete addition; and if "3" were obtained, a true synergy would
exist.
From experience with mixed bacterial infections, when there are suffi-
cient data to make this type of analysis, less than complete addition is seen
more frequently than any other result. As seen in Figure 2, part 1, this
usually means that the agents are acting through unrelated mechanisms and
the fact that complete addition does not occur indicates, for example, that
some of the 25 per cent of the animals most susceptible to A are among
the 25 per cent most susceptible to B. Of course, if each of the animals most
susceptible to A had the same rank order susceptibility to B, then no addi-
tion would occur and a separate mechanism but one with a parallel sus-
ceptibility would have to be postulated. If the agents acted through an
identical mechanism with a final common path, then they would behave,
once the corrections had been made for the slopes and intercepts of the
dose-effect curves by using the linear plots and their E.D. values, with
complete addition (part 2). If the mechanism were exactly the same as it
would be with the same drug used twice, the dose-effect plots would have
the same threshold and slope. Complete addition would also occur in a
situation in which the susceptibility of the two mechanisms were reciprocal
as seen in part 3. These two types of biologic relationships that allow for
complete addition would have to be separated by some type of stratifica-
tion of the hosts by a third criterion if one could be found. Thus, it is pos-
sible, if the endpoint is discrete and a dose-effect curve is derived, to make
some inferences about the mechanisms through which the agent acts.
The endpoint used can be at the end of a sequence if it is the final com-
mon path from the loci of actions when the drugs act at the same step. It
is often possible to test for this by varying the time relationship between
the administrations of the agents.
In a mixed renal infection,8 it was shown that when Staphylococcus
aureus and Candida albicans were administered simultaneously, the results
(deaths) were less than expected by complete addition but more than ex-
pected for either organism alone. However, when the Staphylococcus was
given in a low effective dose, a week before the Candida, it could antagon-
ize the latter. This implies that the sequence is altered when Staphylococcal
administration preceded Candida but not when they were given concur-
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AGENT WITH SUBQUANTAL DOSE
ACTING WITH AGENT WITH DOSE-EFFECT CURVE
1. WITHOUT B
Effect
Dose A
2. B SYNERGISTIC
Effect
Dose A
Function Dose A
Function Dose A
3. B ANTAGONISTIC
Eff fect Effect
Dose A Function Dose A
FIG. 2. Hypothetical analysis of the influence of host factors on summation of ef-
fects of more than one agent.
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rently. This type of analysis should be particularly helpful in studying the
interrelationships between inanimate chemicals or between microbes such
as bacteria nad viruses, provided a dose-effect curve for a common end-
point can be found for each agent. The same model can be used for several
atmospheric pollutants measured simultaneously in epidemiological studies.
In the experimental situation additional information may be gained by
altering the time relationship in addition to the dose.
When one of the agents has no demonstrable dose-effect curve but only
a threshold with an all-or-none response, the situation listed in the Table
under "B" may be found as illustrated in Figure 3. In panel 1, the dose-
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FIG. 3. Hypothetical interaction of two agents when only an all-or-none response
can be measured for one of them.
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effect curve of agent A without B is seen. If the addition of B to an effective
level either lowers the threshold or increases the slope of the dose-effect
curve as in panel 2, the condition might be called synergistic or additive.
Because it is impossible to know just what is to be expected from B, this
is not as precise a definition as the one above and not as much can be in-
ferred from it about pathogenesis. If B were antagonistic to A, the threshold
would be increased and/or the slope lessened as seen in panel 3. In a situa-
tion such as the one encountered by Boren,1 neither agent has a dose-effect
curve and both may be quantal. In this situation, the observations have
qualitative but little quantitative significance. Variation of time relation-
ships might allow some inferences, however. In a review of a large num-
ber of inhalation experiments which have been reported it was found that
the vast majority had insufficient definition of endpoints, dose, or time con-
trols to do more than describe a qualitative picture, thus disallowing analy-
sis of the significance of a combination of agents.
One additional problem is that of the measuring of the dose in the dose-
effect curve. For example, the infection of an animal with tuberculosis by
inhalation is actually a quantal phenomenon if tuberculin sensitization is
used as the endpoint, but can be quantitated if the tubercle counts are made
on the alveolar membranes. If one used only conversion or ultimate death
once the original tubercle had spread, the dose response derived would
merely reflect the innoculum size necessary to get impingement by one in-
haled particle of the correct size on the alveolar membrane. In Boren's
experiment the particle-gas association may be a single effective agent and
a dose-effect curve would reflect this if studied in a time perspective.
As indicated under heading II in the Table, if there are several end-
points involved and each agent plays a role in each, the situation may be-
come quite complex, but careful analysis will allow each situation to be
dissected out.
Thus problems like superinfection versus mixed infection in which each
of the agents in the mixture is involved may be separately defined if varia-
tion in quantitation of an endpoint can be shown to change when the time
relationship between the administration of each of the agents is made. Thus
concurrent administration of two organisms may give results greatly dif-
ferent from those from sequential administration. As indicated by Dr.
Austrian,' the mixed infection situation is the one most frequently en-
countered in the lower airway contamination.
SUMMARY
Interpretation of the action of more than agent is considerably more
difficult than that of a single agent. Careful attention to dose-effect curves
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for each agent and analysis of influences of time relationships between ad-
ministration can allow inferences about mechanism which might give clues
to etiologic and pathogenic mechanisms in human disease.
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